hims glp-1 tracker Inc Hims to begin selling GLP-1

More people than ever are taking GLP-1 receptor agonistsdrugs like Ozempic (semaglutide), Wegovy, and Mounjaro

Alo breaks down the SELECT trial data, debunks the "muscle melting" myth with new NIH research, and shares his protocol for protecting lean mass.

One of the most surprising things people report when starting or adjusting a GLP-1 medication is feeling more hungry, not less.

A timely 2026 release highlighting growing consumer research interest in skin-absorption wellness formats, ingredient themes, product variety, and publicly visible brand information across the Gentle Patches pill-free patch lineup.Los Angeles, CA, April 10, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only

Best combined with mindful eating and regular activity

With incretin-based drugs, much of the reported lean mass loss may not be skeletal muscle, but some is